Acinetobacter baumannii: An Emerging and Important Pathogen.

OBJECTIVE To review the clinical significance, management, and control of Acinetobacter infections. METHODS Literature review. RESULTS Acinetobacter infections have become a major cause of hospital-acquired infections worldwide. Acinetobacter is noted for its ability to survive for long periods on hospital surfaces and equipment, its predilection to develop resistance to multiple antibiotics, its affinity to cause serious infections in critically ill patients, and many well described outbreaks attributable to contamination of a common source. The crude ICU mortality is approximately 40%. Rigorous antibiotic stewardship and infection control measures are critical to prevent the spread of multidrug-resistant Acinetobacter infections. There is also a pressing need for new therapeutic options. CONCLUSION Acinetobacter is an emerging pathogen of increasing significance.

[1]  T. Eckmanns,et al.  Increasing Occurrence of Multidrug-Resistance in Acinetobacter baumannii Isolates From Four German University Hospitals, 2002–2006 , 2010, Infection.

[2]  M. Arduino,et al.  Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. , 1998, The Pediatric infectious disease journal.

[3]  D. Paterson,et al.  Identification of 16S rRNA Methylase-Producing Acinetobacter baumannii Clinical Strains in North America , 2007, Antimicrobial Agents and Chemotherapy.

[4]  H. Rüden,et al.  Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature , 2007, Journal of Hospital Infection.

[5]  J. Bartlett,et al.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. McDonald,et al.  Seasonal Variation of Acinetobacter Infections: 1987–1996 , 1999 .

[7]  B. Charra,et al.  Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. , 2006, The Journal of infection.

[8]  E. Hultén,et al.  Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. , 2004, MMWR. Morbidity and mortality weekly report.

[9]  L. Dijkshoorn,et al.  Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  M. Tong.  Septic complications of war wounds. , 1972, JAMA.

[11]  C. Murray,et al.  Bacteriology of Blood, Wound, and Sputum Cultures from Non-US Casualties Treated in a Combat Support Hospital in Iraq , 2008, Infection Control & Hospital Epidemiology.

[12]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  G. Reid,et al.  Rapid Development of Acinetobacter baumannii Resistance to Tigecycline , 2007, Pharmacotherapy.

[14]  P. Gerner-Smidt,et al.  Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods , 1997, Journal of clinical microbiology.

[15]  J. Garnacho-Montero,et al.  Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. , 1999, Critical care medicine.

[16]  M. Villegas,et al.  Acinetobacter Outbreaks, 1977–2000 , 2003, Infection Control & Hospital Epidemiology.

[17]  J. Patel,et al.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Yong,et al.  Mortality risk factors of Acinetobacter baumannii bacteraemia , 2005, Internal medicine journal.

[19]  M. Safar,et al.  Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Kaufmann,et al.  Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England , 2006, Journal of Clinical Microbiology.

[21]  D. Hospenthal,et al.  Acinetobacter Skin Colonization of US Army Soldiers , 2006, Infection Control & Hospital Epidemiology.

[22]  Y. Siegman-Igra,et al.  Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Desenclos,et al.  VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France , 2006, Emerging Infectious Diseases.

[24]  R. Bonomo,et al.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  D. Raoult,et al.  Acinetobacter baumannii in Human Body Louse , 2004, Emerging infectious diseases.

[26]  M. Kaufmann,et al.  A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. , 2004, The Journal of hospital infection.

[27]  N. Anstey,et al.  Community-Acquired Bacteremic Acinetobacter Pneumonia in Tropical Australia Is Caused by Diverse Strains of Acinetobacter baumannii, with Carriage in the Throat in At-Risk Groups , 2002, Journal of Clinical Microbiology.

[28]  P. Fournier,et al.  The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Paul B. Mann,et al.  Acinetobacter Skin Carriage Among US Army Soldiers Deployed in Iraq , 2007, Infection Control & Hospital Epidemiology.

[30]  J. Quinn,et al.  Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40 , 2006, Antimicrobial Agents and Chemotherapy.

[31]  J. Heritage,et al.  Survival of Acinetobacter baumannii on Dry Surfaces: Comparison of Outbreak and Sporadic Isolates , 1998, Journal of Clinical Microbiology.

[32]  B. Kreiswirth,et al.  Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam , 1994, The Lancet.

[33]  C. Chu,et al.  Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. , 2005, Chest.

[34]  G. Warden,et al.  Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.